Filtered By:
Cancer: Lung Cancer
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 49680 results found since Jan 2013.
Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors
CONCLUSIONS: Our results summarized the efficacy of these treatments and showed that only pembrolizumab can have a role as the first-line treatment of NSCLC. These findings are at variance with those previously reported using the hazard ratio as the outcome measure.PMID:33660798 | DOI:10.26355/eurrev_202102_25083
Source: European Review for Medical and Pharmacological Sciences - March 4, 2021 Category: Drugs & Pharmacology Authors: L Di Spazio L Cancanelli M Rivano M Chiumente D Mengato A Messori Source Type: research
Prognostic nutritional index as a prognostic factor in lung cancer patients receiving chemotherapy: a systematic review and meta-analysis
CONCLUSIONS: We provide preliminary evidence suggesting that lower prognostic nutrition index scores are associated with worse survivability outcomes (progression-free survival and overall survival) in lung cancer patients undergoing chemotherapy. We also show that lower prognostic nutrition index scores correlate with even worse survival outcomes in patients with non-small lung cancer histological subtype of lung cancer. These findings should help clinicians to stratify the risks associated with the chemotherapeutic management of lung cancer patients.PMID:34604956 | DOI:10.26355/eurrev_202109_26783
Source: European Review for Medical and Pharmacological Sciences - October 4, 2021 Category: Drugs & Pharmacology Authors: Q Zhang J Bao Z-Y Zhu M-X Jin Source Type: research
